Mounjaro (tirzepatide) Injection 5mg

Description

Mounjaro (tirzepatide) 5.0 mg

Mounjaro (tirzepatide) is a once-weekly subcutaneous injection used to treat type 2 diabetes and manage weight. By acting as a GIP and GLP-1 receptor agonist, it enhances insulin release, lowers blood sugar, and promotes satiety. It is injected into the stomach, thigh, or upper arm.

Manufacturer – Eli Lilly and Company India Pvt Ltd

Composition: Tirzepatide (5.0 mg)

Storage: Store in a refrigerator (2 – 8°C). Do not freeze.